GGrantIndex
Sort

40,608 grants matching prostate cancer

Administrative Core

$418,701
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U2C · FY2023 · CA

RET Regulation and Targeting in Neuroendocrine Prostate Cancer

$418,696
Justin Michael Drake · University Of Minnesota · R01 · FY2024 · CA

Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer

$418,673
Ganesh S Palapattu · University Of Michigan At Ann Arbor · P50 · FY2020 · CA

Recurrent Prostate Cancer: A Decision Support Guide

$418,652
Healthmark Multimedia, Llc · R44 · FY2002 · CA

CNS sirtuins in radiation-induced vascular permeability and neurodegeneration

$418,626
Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

AR Transgene Model of Prostate Intraepithelial Neoplasia

$418,625
Beth Israel Deaconess Medical Center · R01 · FY2002 · DK

Small Molecule PSMA-Targeted Alpha Therapy

$418,621
Martin G Pomper · Johns Hopkins University · R01 · FY2017 · CA

HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C

$418,592
Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA

IMPROVING THE EFFICACY OF DOCETAXEL-BASED CHEMOTHERAPY FOR HORMONE-REFRACTORY PROSTATE CANCER USING THE NOVEL MECHANISM OF XIAP DEPLETION

$418,585
The Institute For Cancer Research · · FY2010 · Department of Defense

MID ATLANTIC PROSTATE CANCER BANK

$418,545
George Washington University · U01 · FY2000 · CA

Physiology of intrinsically photosensitive retinal ganglion cells

$418,490
Kwoon Y Wong · University Of Michigan At Ann Arbor · R01 · FY2017 · EY

Suicide Gene and Radiation Therapy Clinical Trials

$418,380
Jae Ho Kim · Henry Ford Health System · P01 · FY2007 · CA

Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort

$418,355
Nicola J Camp · University Of Utah · R01 · FY2024 · CA

Research Training in Nephrology

$418,355
Martin R. Pollak · Beth Israel Deaconess Medical Center · T32 · FY2011 · DK

PROSTATE CANCER CHEMOPREVENTION CLINICAL TRIALS

$418,243
New York University School Of Medicine · U01 · FY2000 · CA

Clinical and Analytical Validation of Cancer Biomarkers

$418,200
Daniel W Chan · Johns Hopkins University · U24 · FY2010 · CA

Regulation of metastases by tumor suppressor INPP4B

$418,144
Irina Agoulnik · Florida International University · R15 · FY2014 · CA

Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners

$418,130
Casey Crump · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA

AKT-independent Pathways of Phosphoinositide 3-kinase dependent transformation

$418,107
Charles L Sawyers · Beth Israel Deaconess Medical Center · P01 · FY2008 · CA

COMPUTATIONAL TOOLS FOR CANCER PROTEOMICS

$418,077
Katheryn A Resing · University Of Colorado · R01 · FY2006 · CA

Radiopharmaceuticals for Imaging Nuclear Receptors in Breast and Prostate Cancers

$418,051
John A. Katzenellenbogen · University Of Illinois At Urbana-Champaign · R01 · FY2015 · CA

Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer

$418,039
William J Aronson · University Of California Los Angeles · R01 · FY2019 · CA

New Insight of Androgen Signaling in Prostate Cancer Initiation and Progression

$418,000
Zijie Sun · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

San Juan Minority - Based Community Clinical Oncology Program

$417,931
Luis Baez · Municipio De San Juan · U10 · FY2011 · CA

8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA

$417,819
Thomas Jefferson University · R01 · FY2002 · CA